PRESS RELEASE published on 06/18/2024 at 07:30, 1 year 10 months ago Succès d'une augmentation de capital d'un montant global de 12,8 MEUR, avec le soutien d'HuvePharma, partenaire industriel de Fermentalg, et de Bpifrance, pour créer le champion européen des solutions par fermentation de microalgues Fermentalg réalise une augmentation de capital de 12,8 M€ pour renforcer sa position de leader européen en biotechnologie marine des microalgues, avec HuvePharma comme nouvel actionnaire de référence Augmentation De Capital FERMENTALG Microalgues HuvePharma Biotechnologie Marine
PRESS RELEASE published on 06/18/2024 at 07:30, 1 year 10 months ago Successful capital increase for a total amount of EUR12.8m, with the support of Fermentalg's industrial partner HuvePharma and Bpifrance, to create the European champion for microalgae fermentation solutions Fermentalg successfully completes €12.8 million capital increase to support 2024-2026 strategic plan and strengthen its position as a leader in sustainable marine microalgae solutions Sustainable Solutions Capital Increase FERMENTALG HuvePharma Marine Microalgae
BRIEF published on 06/17/2024 at 17:40, 1 year 10 months ago Fermentalg Launches €12 Million Capital Increase with HuvePharma's Support Fundraising Capital Increase FERMENTALG Microalgae HuvePharma
BRIEF published on 06/17/2024 at 17:40, 1 year 10 months ago Fermentalg lance une augmentation de capital de 12 millions d'euros avec le soutien de HuvePharma Augmentation De Capital Collecte De Fonds Microalgues Fermentation HuvePharma
PRESS RELEASE published on 06/17/2024 at 17:35, 1 year 10 months ago Launch of a capital increase open to institutional and retail investors for a total of approximately EUR12 million, with the support of HuvePharma, Fermentalg's industrial partner Fermentalg announces a €12 million capital increase with support from HuvePharma to lead in microalgae fermentation solutions. Sales targets raised amidst strong growth momentum. Funds to achieve financial equilibrium by 2026 Capital Increase Sales Targets FERMENTALG HuvePharma Microalgae Fermentation Solutions
PRESS RELEASE published on 06/17/2024 at 17:35, 1 year 10 months ago Lancement d'une augmentation de capital ouverte aux investisseurs institutionnels et aux particuliers d'un montant global d'environ 12 MEUR, avec le soutien d'HuvePharma, partenaire industriel de Fermentalg Fermentalg lance une augmentation de capital de 12 M€ avec le soutien d'HuvePharma pour devenir le leader européen des solutions par fermentation de microalgues Augmentation De Capital FERMENTALG Microalgues Fermentation HuvePharma
BRIEF published on 06/04/2024 at 18:05, 1 year 10 months ago Informations sur le nombre d'actions et de droits de vote de Fermentalg Droits De Vote Actions AMF Publication Financière FERMENTALG
BRIEF published on 06/04/2024 at 18:05, 1 year 10 months ago Information on the number of shares and voting rights of Fermentalg Voting Rights Actions AMF Financial Publication FERMENTALG
PRESS RELEASE published on 06/04/2024 at 18:00, 1 year 10 months ago Informations relatives au nombre total de droits de vote et d'actions Fermentalg communique le nombre total de droits de vote et d'actions conformément à la réglementation. Prochaine publication sur le chiffre d'affaires. Expertise en bioindustrie des microalgues Droits De Vote Actions FERMENTALG Microalgues Bioindustrie
BRIEF published on 05/23/2024 at 15:35, 1 year 11 months ago Fermentalg publie la quatrième édition de sa Lettre aux actionnaires Actionnaires Euronext Growth Publication Financière FERMENTALG Microalgues
Published on 05/02/2026 at 21:00, 3 hours 53 minutes ago GECC Subsidiary Provides Update on its Lawsuit for Damages Against the Lender of the Atmosphere Project
Published on 05/02/2026 at 01:30, 23 hours 23 minutes ago Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 1 day ago CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 1 day ago Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 1 day ago Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Published on 05/02/2026 at 15:35, 9 hours 18 minutes ago Ecuador's banana sector renews labor agreement, with jobs meeting global standards
Published on 05/01/2026 at 19:23, 1 day 5 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/01/2026 at 17:45, 1 day 7 hours ago Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)
Published on 04/30/2026 at 21:21, 2 days 3 hours ago CP -Mise à disposition du rapport financier annuel 2025
Published on 04/30/2026 at 20:00, 2 days 4 hours ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 20:00, 2 days 4 hours ago AMA Corp PLC : Résultats 2025 & Chiffre d'affaires du 1er trimestre 2026
Published on 04/30/2026 at 19:16, 2 days 5 hours ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:16, 2 days 5 hours ago AXA annonce les résultats de son Assemblée Générale